FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386660437> ?p ?o ?g. }

• W4386660437 abstract "Abstract Introduction Arterial hypertension (AH) is the most common cardiovascular (CV) diseases and one of the major a risk factor for CV complications and mortality. An important reason for the development and progression of a number of CV diseases are epigenetic factors regulating gene expression, which include microRNAs. MicroRNA-133a is one the epigenetics factor, which has cardioprotective properties, but its role in the development of left ventricular hypertrophy (LVH) in patients with AH, including men, is not well understood. Purpose The aim of the study was to investigate the circulating microRNA-133a levels, its associations with left ventricular (LV) parameters and LVH in men with AH. Methods In study was included 57 men with AH grades 2–3 aged 43 to 64. The main group consists of 32 patients with LVH and the comparison group consists of 25 patients without LVH. The main and the comparison groups were comparable in age and duration of hypertension. The control group consisted of 22 practically healthy men of comparable age. The LVH was determined according to the 2018 ESC/ESH guidelines. Circulating plasma microRNA-133a levels were obtained by polymerase chain reaction using the CFX96 Touch System, “TaqMan microRNA Assay” and “TaqMan® Universal PCR Master Mix” reagent kits. Results In men with AH (total group) the levels of microRNA-133a were significantly lower than in practically healthy men in the control group (0.212 [0.091; 0.364]) vs (0.402 [0.178; 0.513]), p&lt;0.05). The levels of microRNA-133a in main group were significantly lower than in comparison group and control group (0.125 [0.078; 0.295] vs 0.276 [0.126; 0.397], p&lt;0.05 and 0.402 [0.178; 0.513]), p&lt;0.05). In the main group (men with AH and LVH) there was a statistically significant negative correlation between microRNA-133a levels and LV mass index (R=−0.42, p&lt;0.01) with no significant correlation with ejection fraction or E/e' (averaged) ratio (p&gt;0.05). In men with AH of the comparison group (without LVH) there were not significant associations of microRNA-133a levels with LV parameters (p&gt;0.05). Conclusion The obtained results may indicate a significant role of decreased circulating plasma microRNA-133a levels in men with AH in the pathogenesis and development of the LVH. Funding Acknowledgement Type of funding sources: None." @default.
• W4386660437 created "2023-09-13" @default.
• W4386660437 creator A5004717788 @default.
• W4386660437 creator A5015440372 @default.
• W4386660437 creator A5042482747 @default.
• W4386660437 creator A5056555057 @default.
• W4386660437 date "2021-10-01" @default.
• W4386660437 modified "2023-10-18" @default.
• W4386660437 title "Circulating microRNA-133a and its associations with left ventricular hypertrophy in men with arterial hypertension" @default.
• W4386660437 doi "https://doi.org/10.1093/eurheartj/ehab724.2289" @default.
• W4386660437 hasPublicationYear "2021" @default.
• W4386660437 type Work @default.
• W4386660437 citedByCount "0" @default.
• W4386660437 crossrefType "journal-article" @default.
• W4386660437 hasAuthorship W4386660437A5004717788 @default.
• W4386660437 hasAuthorship W4386660437A5015440372 @default.
• W4386660437 hasAuthorship W4386660437A5042482747 @default.
• W4386660437 hasAuthorship W4386660437A5056555057 @default.
• W4386660437 hasBestOaLocation W43866604371 @default.
• W4386660437 hasConcept C104317684 @default.
• W4386660437 hasConcept C126322002 @default.
• W4386660437 hasConcept C143660080 @default.
• W4386660437 hasConcept C145059251 @default.
• W4386660437 hasConcept C164705383 @default.
• W4386660437 hasConcept C167414201 @default.
• W4386660437 hasConcept C185592680 @default.
• W4386660437 hasConcept C2776002628 @default.
• W4386660437 hasConcept C48023723 @default.
• W4386660437 hasConcept C55493867 @default.
• W4386660437 hasConcept C71924100 @default.
• W4386660437 hasConcept C84393581 @default.
• W4386660437 hasConceptScore W4386660437C104317684 @default.
• W4386660437 hasConceptScore W4386660437C126322002 @default.
• W4386660437 hasConceptScore W4386660437C143660080 @default.
• W4386660437 hasConceptScore W4386660437C145059251 @default.
• W4386660437 hasConceptScore W4386660437C164705383 @default.
• W4386660437 hasConceptScore W4386660437C167414201 @default.
• W4386660437 hasConceptScore W4386660437C185592680 @default.
• W4386660437 hasConceptScore W4386660437C2776002628 @default.
• W4386660437 hasConceptScore W4386660437C48023723 @default.
• W4386660437 hasConceptScore W4386660437C55493867 @default.
• W4386660437 hasConceptScore W4386660437C71924100 @default.
• W4386660437 hasConceptScore W4386660437C84393581 @default.
• W4386660437 hasIssue "Supplement_1" @default.
• W4386660437 hasLocation W43866604371 @default.
• W4386660437 hasOpenAccess W4386660437 @default.
• W4386660437 hasPrimaryLocation W43866604371 @default.
• W4386660437 hasRelatedWork W2013780032 @default.
• W4386660437 hasRelatedWork W2017405215 @default.
• W4386660437 hasRelatedWork W2074656274 @default.
• W4386660437 hasRelatedWork W2095147394 @default.
• W4386660437 hasRelatedWork W2127007225 @default.
• W4386660437 hasRelatedWork W2239476963 @default.
• W4386660437 hasRelatedWork W2485968534 @default.
• W4386660437 hasRelatedWork W3032350403 @default.
• W4386660437 hasRelatedWork W3132152112 @default.
• W4386660437 hasRelatedWork W3212788949 @default.
• W4386660437 hasVolume "42" @default.
• W4386660437 isParatext "false" @default.
• W4386660437 isRetracted "false" @default.
• W4386660437 workType "article" @default.